Spinal Tech

A barrage of lawsuits regarding off-label use for Medtronic's Infuse bone morphogenic protein product may be right around the corner, according to various news sources.

Since June: Medical device company ArthroCare sold its Parallax and Contour products, which are used during spine surgery, to NeuroTherm. Sports medicine device company Cayenne Medical entered into a co-marketing partnership with Parametrics Medical to market Parametrics’ allografts, which are…

New technology associated with gene therapy and stem cell research is driving the orthopedic biomaterials market, which represents 14 percent of the global orthopedics market, according to a report from Kalorama Information.

Stryker Joint Preservation, a business unit of Stryker Orthopaedics, has entered into an exclusive partnership with RegenLab to distribute Stryker's RegenKit-THT for the preparation of autologous platelet-rich plasma, according to a Stryker news release.

InVivo Therapeutics appointed Jonathan R. Slotkin, MD, a neurosurgeon at Washington Brain & Spine Institute in Washington, DC, as the company's new medical director, according to a company news release.

Marc W. Hungerford, MD, director of joint replacement and reconstruction at Mercy Medical Center in Baltimore recently became the first orthopedic surgeon to perform the MAKOplasty partial knee resurfacing procedure using the RIO Robotic Arm in the state of Maryland,…

Germany-based orthopedic device company IlluminOss Medical announced the first use of its minimally invasive ankle fracture repair system, according to a company news release.

The Food and Drug Administration granted 510(k) clearances to 12 spine-related devices in June, according to an FDA report.

Biomet reported net sales of $715.2 million during the fourth quarter of the 2011 fiscal year, which is an increase of 2 percent over the same period last year, according to a company news release.

The Food and Drug Administration granted 29 orthopedic- and spine-related 510(k) device clearances in June, according to an FDA report.